Analysts Set Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Target Price at $28.00

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has been given an average recommendation of “Reduce” by the ten analysts that are currently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $28.00.

Several equities analysts have recently issued reports on the company. Wall Street Zen lowered Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Wednesday, May 6th. Jefferies Financial Group raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research note on Friday, May 8th. Finally, Citigroup reissued a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its stake in shares of Fresenius Medical Care AG & Co. KGaA by 14.2% during the first quarter. AQR Capital Management LLC now owns 14,297 shares of the company’s stock worth $356,000 after buying an additional 1,777 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 160.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 37,610 shares of the company’s stock valued at $1,075,000 after acquiring an additional 23,163 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the 2nd quarter. American Century Companies Inc. now owns 29,173 shares of the company’s stock valued at $833,000 after acquiring an additional 5,127 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock valued at $146,000 after acquiring an additional 896 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 141.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,906 shares of the company’s stock valued at $83,000 after acquiring an additional 1,704 shares in the last quarter. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care AG & Co. KGaA Stock Performance

NYSE FMS opened at $24.12 on Friday. The firm’s 50 day simple moving average is $22.74 and its 200 day simple moving average is $22.86. The firm has a market capitalization of $12.96 billion, a price-to-earnings ratio of 12.70, a P/E/G ratio of 4.35 and a beta of 0.78. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.40. Fresenius Medical Care AG & Co. KGaA has a 1 year low of $20.02 and a 1 year high of $27.64.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its quarterly earnings data on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The business had revenue of $5.34 billion during the quarter. As a group, research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The business also recently declared an annual dividend, which was paid on Monday, June 8th. Investors of record on Friday, May 22nd were issued a dividend of $0.8716 per share. This is a boost from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. The ex-dividend date of this dividend was Friday, May 22nd. This represents a dividend yield of 402.0%. Fresenius Medical Care AG & Co. KGaA’s payout ratio is presently 32.11%.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high?flux dialyzers and bloodlines.